GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » Total Liabilities

Lobe Sciences (Lobe Sciences) Total Liabilities : $2.48 Mil (As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences Total Liabilities?

Lobe Sciences's Total Liabilities for the quarter that ended in Feb. 2024 was $2.48 Mil.

Lobe Sciences's quarterly Total Liabilities increased from Aug. 2023 ($1.83 Mil) to Nov. 2023 ($2.10 Mil) and increased from Nov. 2023 ($2.10 Mil) to Feb. 2024 ($2.48 Mil).

Lobe Sciences's annual Total Liabilities increased from Aug. 2021 ($0.64 Mil) to Aug. 2022 ($1.01 Mil) and increased from Aug. 2022 ($1.01 Mil) to Aug. 2023 ($1.83 Mil).


Lobe Sciences Total Liabilities Historical Data

The historical data trend for Lobe Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Total Liabilities Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.68 0.64 1.01 1.83

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 1.48 1.83 2.10 2.48

Lobe Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lobe Sciences's Total Liabilities for the fiscal year that ended in Aug. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.825+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=1.83

Total Liabilities=Total Assets (A: Aug. 2023 )-Total Equity (A: Aug. 2023 )
=1.706--0.119
=1.83

Lobe Sciences's Total Liabilities for the quarter that ended in Feb. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.476+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=2.48

Total Liabilities=Total Assets (Q: Feb. 2024 )-Total Equity (Q: Feb. 2024 )
=1.562--0.915
=2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lobe Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (Lobe Sciences) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.